1. Cryptococcus neoformans var
Cryptococcus neoformans var. neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia 
K. Assing, H. Birgens, M. Arendrup 
Clinical Microbiology and Infection 
Volume 9, Issue 5, Pages (May 2003)
DOI: /j x
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Etest susceptibility testing of fluconazole and amphotericin B. Susceptibility testing was performed according to the manufacturer's recommendations. The isolate was regarded as fluconazole resistant. The Etest endpoint of amphotericin B was 0.25 mg/L.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2
Seventy-two-hour reading of NCCLS microdilution susceptibility determination. Growth inhibition curve with two-fold drug dilutions and untreated control cultures. OD values read by spectrophotometer. Fluconazole 80% inhibition cut-off 0.122, amphotericin B cut-off MICs: fluconazole 32 mg/L, amphotericin B 1 mg/L. Ampho, amphotericin B; Fluco, fluconazole.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions